IPAS158
Concessão de registro
RPI 2495
10/30/2018
Back to search
Official data from INPI
NOVELION THERAPEUTICS
Did you know this trademark is already registered in Brazil?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Registro de marca em vigorType: WordOffice: Brazil
Quick snapshot
NOVELION THERAPEUTICS
ST13
BR500000912372974Class
5
Filing
912372974
Registration
912372974
Progress at the INPI
- Filing03/03/17
- Publication03/28/17
- Examination
- Allowance07/31/18
- Grant10/30/18
- In force10/30/28
The registration was granted on 10/30/2018 and is in force until 10/30/2028, when it must be renewed.
Protection valid until:10/30/2028
Latest action published by the INPI: 10/30/2018. We update with every new RPI gazette, published weekly.
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
INPI status
Registro de marca em vigor
Case type
Application and registration
Recorded events
3
Latest update
10/30/2018
Trademark type
Word
Nice classes
5
Filing date
03/03/2017
Registration date
10/30/2018
Expiration date
10/30/2028
Complete case details
Structured fields from the responsible authority and the official record.
Nature
De Produto
Responsible office
Brazil
Owner type
NÃO RESIDENTE
Owner location
US
Holders and representatives
Holders
Aegerion Pharmaceuticals, Inc.
Representatives
Dannemann SiemsenVer perfil do escritório
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Produtos farmacêuticos, preparações medicinais
Publications
History of INPI decisions and trademark events.
3 publications found
IPAS029
Deferimento do pedido
RPI 2482
07/31/2018
IPAS009
Publicação de pedido de registro para oposição (exame formal concluído)
RPI 2412
03/28/2017
Aegerion Pharmaceuticals, Inc. also protects technology and design at the INPI
3 patent applications under the same owner.
Related trademarks
Other trademarks by Aegerion Pharmaceuticals, Inc.
Continuous trademark protection
Get notified about every new filing that threatens NOVELION THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor INPI for you and alert you in time to oppose — before conflicts become losses.